# Salivary Therapeutic Drug Monitoring of Anti-Tuberculosis Drugs

> **NCT03080012** · — · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 24 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **OTHER:** Saliva sampling
- **OTHER:** Plasma/serum sampling

## Key facts

- **NCT ID:** NCT03080012
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-07
- **Primary completion:** 2018-05-02
- **Final completion:** 2018-05-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03080012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03080012, "Salivary Therapeutic Drug Monitoring of Anti-Tuberculosis Drugs". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT03080012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*